{"id":42132,"date":"2025-09-23T16:42:51","date_gmt":"2025-09-23T08:42:51","guid":{"rendered":"https:\/\/flcube.com\/?p=42132"},"modified":"2025-09-23T16:42:52","modified_gmt":"2025-09-23T08:42:52","slug":"probio-and-immunofoco-forge-global-cgt-manufacturing-alliance","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=42132","title":{"rendered":"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance"},"content":{"rendered":"\n<p><strong>ProBio<\/strong>, a subsidiary of <strong>GenScript Biotech Corporation (<a href=\"https:\/\/www.google.com\/finance\/quote\/1548:HKG\">HKG: 1548<\/a>)<\/strong>, and China\u2011based <strong>Immunofoco<\/strong> have inked a strategic cooperation agreement to jointly commercialise cell\u2011and\u2011gene\u2011therapy (CGT) products. The partnership extends their proven early\u2011clinical collaboration into full\u2011scale CDMO services, positioning both firms to accelerate the global rollout of next\u2011generation CGT drugs.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-what-the-deal-covers\">What the Deal Covers<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Integrated Manufacturing<\/strong> \u2013 ProBio will supply end\u2011to\u2011end GMP production, from process development to commercial scale.<\/li>\n\n\n\n<li><strong>Quality &amp; Compliance<\/strong> \u2013 Leveraging ProBio\u2019s robust quality\u2011system framework, the alliance will uphold the highest regulatory standards across all stages of CGT development.<\/li>\n\n\n\n<li><strong>Commercial Momentum<\/strong> \u2013 Immunofoco gains access to ProBio\u2019s manufacturing network, enabling rapid product launch and market penetration.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-strategic-significance\">Strategic Significance<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Supply\u2011Chain Resilience<\/strong> \u2013 The tie\u2011up mitigates the current bottleneck in CGT production, a critical need as global demand surges.<\/li>\n\n\n\n<li><strong>Innovation Acceleration<\/strong> \u2013 By aligning clinical and commercial pipelines, the partnership promises shorter time\u2011to\u2011market for breakthrough therapies.<\/li>\n\n\n\n<li><strong>Global Reach<\/strong> \u2013 With ProBio\u2019s established international footprint, Immunofoco\u2019s therapies can be distributed worldwide, supporting the global CGT ecosystem.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>ProBio, a subsidiary of GenScript Biotech Corporation (HKG: 1548), and China\u2011based Immunofoco have inked a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":42133,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[521,872,2253,719],"class_list":["post-42132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-genscript-biotech","tag-hkg-1548","tag-immunofoco","tag-probio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ProBio and Immunofoco Forge Global CGT Manufacturing Alliance - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"ProBio, a subsidiary of GenScript Biotech Corporation (HKG: 1548), and China\u2011based Immunofoco have inked a strategic cooperation agreement to jointly commercialise cell\u2011and\u2011gene\u2011therapy (CGT) products. The partnership extends their proven early\u2011clinical collaboration into full\u2011scale CDMO services, positioning both firms to accelerate the global rollout of next\u2011generation CGT drugs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=42132\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance\" \/>\n<meta property=\"og:description\" content=\"ProBio, a subsidiary of GenScript Biotech Corporation (HKG: 1548), and China\u2011based Immunofoco have inked a strategic cooperation agreement to jointly commercialise cell\u2011and\u2011gene\u2011therapy (CGT) products. The partnership extends their proven early\u2011clinical collaboration into full\u2011scale CDMO services, positioning both firms to accelerate the global rollout of next\u2011generation CGT drugs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=42132\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-23T08:42:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-23T08:42:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2316.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42132#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42132\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance\",\"datePublished\":\"2025-09-23T08:42:51+00:00\",\"dateModified\":\"2025-09-23T08:42:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42132\"},\"wordCount\":186,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42132#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2316.webp\",\"keywords\":[\"Genscript Biotech\",\"HKG: 1548\",\"Immunofoco\",\"ProBio\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42132#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42132\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=42132\",\"name\":\"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42132#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42132#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2316.webp\",\"datePublished\":\"2025-09-23T08:42:51+00:00\",\"dateModified\":\"2025-09-23T08:42:52+00:00\",\"description\":\"ProBio, a subsidiary of GenScript Biotech Corporation (HKG: 1548), and China\u2011based Immunofoco have inked a strategic cooperation agreement to jointly commercialise cell\u2011and\u2011gene\u2011therapy (CGT) products. The partnership extends their proven early\u2011clinical collaboration into full\u2011scale CDMO services, positioning both firms to accelerate the global rollout of next\u2011generation CGT drugs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42132#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42132\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42132#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2316.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2316.webp\",\"width\":1080,\"height\":608,\"caption\":\"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42132#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance - Insight, China&#039;s Pharmaceutical Industry","description":"ProBio, a subsidiary of GenScript Biotech Corporation (HKG: 1548), and China\u2011based Immunofoco have inked a strategic cooperation agreement to jointly commercialise cell\u2011and\u2011gene\u2011therapy (CGT) products. The partnership extends their proven early\u2011clinical collaboration into full\u2011scale CDMO services, positioning both firms to accelerate the global rollout of next\u2011generation CGT drugs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=42132","og_locale":"en_US","og_type":"article","og_title":"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance","og_description":"ProBio, a subsidiary of GenScript Biotech Corporation (HKG: 1548), and China\u2011based Immunofoco have inked a strategic cooperation agreement to jointly commercialise cell\u2011and\u2011gene\u2011therapy (CGT) products. The partnership extends their proven early\u2011clinical collaboration into full\u2011scale CDMO services, positioning both firms to accelerate the global rollout of next\u2011generation CGT drugs.","og_url":"https:\/\/flcube.com\/?p=42132","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-23T08:42:51+00:00","article_modified_time":"2025-09-23T08:42:52+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2316.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=42132#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=42132"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance","datePublished":"2025-09-23T08:42:51+00:00","dateModified":"2025-09-23T08:42:52+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=42132"},"wordCount":186,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=42132#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2316.webp","keywords":["Genscript Biotech","HKG: 1548","Immunofoco","ProBio"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=42132#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=42132","url":"https:\/\/flcube.com\/?p=42132","name":"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=42132#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=42132#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2316.webp","datePublished":"2025-09-23T08:42:51+00:00","dateModified":"2025-09-23T08:42:52+00:00","description":"ProBio, a subsidiary of GenScript Biotech Corporation (HKG: 1548), and China\u2011based Immunofoco have inked a strategic cooperation agreement to jointly commercialise cell\u2011and\u2011gene\u2011therapy (CGT) products. The partnership extends their proven early\u2011clinical collaboration into full\u2011scale CDMO services, positioning both firms to accelerate the global rollout of next\u2011generation CGT drugs.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=42132#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=42132"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=42132#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2316.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2316.webp","width":1080,"height":608,"caption":"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=42132#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"ProBio and Immunofoco Forge Global CGT Manufacturing Alliance"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2316.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42132"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42132\/revisions"}],"predecessor-version":[{"id":42134,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42132\/revisions\/42134"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/42133"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=42132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=42132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}